Cutaneous Infection With Rapidly-Growing Mycobacterial Infection Following Heart Transplant: A Case Report and Review of the Literature

Transplantation Proceedings

Volumn 38, Issue 5, 2006, Pages 1526-1529

  Freudenberger, R S ^a   Simafranca, S M ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIMYCOBACTERIAL AGENT; AZATHIOPRINE; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; CREATININE; CYCLOSPORIN; DOXYCYCLINE; ERYTHROMYCIN; KANAMYCIN; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE;

ADULT; ANAMNESIS; ANTIBIOTIC SENSITIVITY; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DIABETES MELLITUS; ERYTHEMA; EXPOSURE; GRAFT REJECTION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INJURY; KIDNEY FAILURE; LEG SWELLING; MALE; MEDICAL LITERATURE; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; PAPULE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PUNCH BIOPSY; SKIN INFECTION; SLEEP APNEA SYNDROME;

AGED; ANTI-BACTERIAL AGENTS; BIOPSY; CLARITHROMYCIN; HEART TRANSPLANTATION; HUMANS; LEG; MALE; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; POSTOPERATIVE COMPLICATIONS; SKIN DISEASES, BACTERIAL;

EID: 33745194311     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.02.126     Document Type: Article

References (13)

1. Patel R., Roberts G.D., Keating M.R., et al. Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. Clin Infect Dis 19 (1994) 263
2. Novick R.J., Moreno-Cabral C.E., Stinson E.B., et al. Nontuberculous mycobacterial infections in heart transplant recipients. a seventeen-year experience. J Heart Transplant 9 (1990) 357
3. Bruckner D.A., Colonna P., and Bearson B.L. Nomenclature for aerobic and facultative bacteria. Clin Infect Dis 29 (1999) 713
4. Eisenstadt J., and Hall G.S. Microbiology and classification of mycobacteria. Clin Dermatol 13 (1995) 197
5. Sastry B.P.J. Cutaneous infections with rapidly growing mycobacteria. Clin Dermatol 13 (1995) 265
6. Hautmann G., and Lotti T. Atypical mycobacterial infections of the skin. Dermatol Clin 12 (1994) 657
7. Ingram C.W., Tanner D.C., Durack D.T., et al. Disseminated infection with rapidly growing mycobacteria. Clin Infect Dis 16 (1993) 463
8. Wallace Jr. R.J., Brown B.A., and Onyi G.O. Susceptibilities of Mycobacterium fortuitum biovar, fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin and amoxicillin-clavulanic acid. Antimicrob Agents Chemother 35 (1991) 773
9. Brown B.A., Wallace Jr. R.J., Onyi G.O., et al. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother 36 (1992) 180
10. Wallace Jr. R.J., Brown B.A., and Onyi G.O. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae. importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 166 (1992) 405
11. Wallace Jr. R.J., Tanner D., Brennan P.J., et al. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 119 (1993) 482
12. ATS. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156 (1997) S1
13. Tebas P., Sultan F., Wallace Jr. R.J., et al. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. Clin Infect Dis 20 (1995) 443